[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1262378, "exercisedValue": 0, "unexercisedValue": 18056}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 713958, "exercisedValue": 0, "unexercisedValue": 5625}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 696350, "exercisedValue": 0, "unexercisedValue": 4219}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Pinkosky", "title": "Vice President of Drug Discovery of Early Pre-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.81, "open": 1.83, "dayLow": 1.7, "dayHigh": 1.8799, "regularMarketPreviousClose": 1.81, "regularMarketOpen": 1.83, "regularMarketDayLow": 1.7, "regularMarketDayHigh": 1.8799, "payoutRatio": 0.0, "beta": 0.825, "forwardPE": 9.349999, "volume": 5126241, "regularMarketVolume": 5126241, "averageVolume": 4782152, "averageVolume10days": 5300230, "averageDailyVolume10Day": 5300230, "bid": 1.8, "ask": 1.92, "bidSize": 52, "askSize": 52, "marketCap": 374374016, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 3.94, "priceToSalesTrailing12Months": 1.3962668, "fiftyDayAverage": 1.2098, "twoHundredDayAverage": 1.65975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 853744000, "profitMargins": -0.35837, "floatShares": 198336138, "sharesOutstanding": 198199008, "sharesShort": 22097452, "sharesShortPriorMonth": 24113664, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.111499995, "heldPercentInsiders": 0.00567, "heldPercentInstitutions": 0.59278, "shortRatio": 7.25, "shortPercentOfFloat": 0.111999996, "impliedSharesOutstanding": 200200000, "bookValue": -2.167, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -96088000, "trailingEps": -0.5, "forwardEps": 0.2, "enterpriseToRevenue": 3.184, "enterpriseToEbitda": -31.149, "52WeekChange": -0.016304374, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.87, "targetHighPrice": 16.0, "targetLowPrice": 1.6, "targetMeanPrice": 5.8, "targetMedianPrice": 4.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 114633000, "totalCashPerShare": 0.573, "ebitda": -27408000, "totalDebt": 594003008, "totalRevenue": 268124992, "revenuePerShare": 1.367, "grossProfits": 131892000, "revenueGrowth": 0.116, "grossMargins": 0.4919, "ebitdaMargins": -0.10222, "operatingMargins": 0.18242, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754697561, "regularMarketTime": 1754683201, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.31492, "regularMarketPrice": 1.87, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "postMarketChangePercent": 0.502674, "postMarketPrice": 1.8794, "postMarketChange": 0.00940001, "regularMarketChange": 0.0600001, "regularMarketDayRange": "1.7 - 1.8799", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4782152, "fiftyTwoWeekLowChange": 1.1800001, "fiftyTwoWeekLowChangePercent": 1.710145, "fiftyTwoWeekRange": "0.69 - 3.94", "fiftyTwoWeekHighChange": -2.0700002, "fiftyTwoWeekHighChangePercent": -0.52538073, "fiftyTwoWeekChangePercent": -1.6304374, "earningsTimestamp": 1754397000, "earningsTimestampStart": 1762259400, "earningsTimestampEnd": 1762259400, "earningsCallTimestampStart": 1754395200, "earningsCallTimestampEnd": 1754395200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.5, "epsForward": 0.2, "epsCurrentYear": -0.05, "priceEpsCurrentYear": -37.399998, "fiftyDayAverageChange": 0.6602, "fiftyDayAverageChangePercent": 0.54571, "twoHundredDayAverageChange": 0.21025002, "twoHundredDayAverageChangePercent": 0.12667571, "priceToBook": -0.8629441, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]